The invention discloses a
traditional Chinese medicine formula for treating anaphylactoid purpura, and relates to the technical field of
traditional Chinese medicine prescriptions, and the
traditional Chinese medicine formula comprises the following raw materials in parts by weight: 80-120 parts of folium isatidis, 80-120 parts of herba cepbalanoplosis segeti, 80-120 parts of cornu bubali, 80-120 parts of hairyvein agrimony, 80-120 parts of carbonized
sanguisorba root, 80-120 parts of
rehmannia, 80-120 parts of moutan
bark, 80-120 parts of pseudo-
ginseng, 80-120 parts of radix paeoniae alba, 80-120 parts of
astragalus membranaceus, 80-120 parts of
selaginella tamariscina and 80-120 parts of bighead atractylodes
rhizome. Through the multi-target synergistic effect of removing heat to cool blood, astringing to stop bleeding and tonifying qi to strengthen superficies, the
curative effect of anaphylactoid purpura is remarkably improved, and the traditional Chinese
medicine composition is free of
hormone dependence risk and especially suitable for long-term use by children and chronic patients; the
dissolution rate of active ingredients is optimized by adopting a step-by-step extraction process, and the quality is controllable in combination with an
HPLC fingerprint spectrum; the pharmaceutical composition is expanded to
immune thrombocytopenia and other indications, and has safety, stability and clinical application flexibility.